Answers are grounded in this paper and cite their sources.
With the increasing prevalence of the obesity epidemic, non-alcoholic fatty liver disease (NAFLD) represent the most common liver disease worldwide and one of the important causes of hepatocellular carcinoma development. Also, it is strongly associated with type 2 diabetes mellitus. Metabolic inflammation has been suggested to play a central role in NAFLD progression. Monocytes represent a key player in meta-inflammation. Circulating monocytes, adipose tissue macrophages (ATM), and liver resident macrophages have roles in NAFLD development and progression. Adipose tissue macrophages accumulate as a result of adipose tissue hypoxia, they produce huge amount of cytokines inducing insulin resistance and excess fat accumulation in the liver. In this review, we highlight the burden of NAFLD, its association to metabolic parameters and obesity, with illustration of obesity induced inflammation and pathogenic pathways involved in insulin resistance development. We pointed to the plasticity of circulating monocytes, phenotypic and functional alteration of their subsets in NAFLD, and the therapeutic approaches targeting macrophages and their effects on improvement of insulin resistance and NAFLD progression.
No takes yet. Share an insight, caveat, or question.
Shaarawe et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: